Home
Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Market Share Analysis for June 2026

广州市香雪制药股份有限公司

Health > Biotechnology and Pharmaceuticals

Domainxphcn.com

Year Founded--

Employees1001 - 5000

Annual Revenue--

Xiangxue Pharmaceutical

Xiangxue Pharmaceutical (including company regionals)

xphcn.com

See more website traffic and engagement information

Total visits to Xiangxue Pharmaceutical's top domains

Understand Xiangxue Pharmaceutical market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Xiangxue Pharmaceutical's top domains

Analyze Xiangxue Pharmaceutical engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Xiangxue Pharmaceutical's top domains

See how Xiangxue Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Xiangxue Pharmaceutical top competitors by domain

Top similar sites in June 2026, ranked by their affinity

improve-medical.comCompany NameImprove MedicalEmployees501 - 1000HQChina, GuangzhouAnnual revenue--Total visits128Health > Health - Other

Top technologies used by Xiangxue Pharmaceutical

These are the website technologies, by industry, used by Xiangxue Pharmaceutical top domains

Advertising (1)

PubMatic

Audio Video Media (1)

VideoJS

Conversion & Analytics (1)

CNZZ

Mobile (1)

Meta Viewport

More Technologies

2

See all

News & Signals from Xiangxue Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsXphcn partnered with Athenex, Inc. on Dec 17th '19.Guangzhou Xiangxue Pharmaceutical Co., Ltd. ("Xiangxue") has expandedits strategic partnership with Athenex, Inc. (Nasdaq: ATNX) to exclusively developand commercialize Athenex's oncology product candidates Oral Paclitaxel (boththe capsule and the tablet formulations), Oral Irinotecan, as well as Tirbanibulin(KX2-391,also known as KX-01) Ointment, including for the treatment ofactinic keratosis (AK) in China.